Ken Cacciatore analyst TD COWEN

Currently out of the existing stock ratings of Ken Cacciatore, 84 are a BUY (68.85%), 37 are a HOLD (30.33%), 1 are a SELL (0.82%).

Ken Cacciatore

Work Performance Price Targets & Ratings Chart

Analyst Ken Cacciatore works at TD COWEN with a stock forecast success ratio of 37.27% fulfilled within 96.09 days on average.

Ken Cacciatore’s has documented 260 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARQT, Arcutis Biotherapeutics  at 09-Aug-2023.

Wall Street Analyst Ken Cacciatore

Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 3/31/2020. The price target of $8 was fulfilled within 29 days with a profit of $4 (100%) receiving and performance score of 34.48.

Average potential price target upside

ADMS Adamas Pharmaceuticals AGN Allergan plc BCRX BioCryst Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd ENDP Endo International PLC HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC TEVA Teva Pharma Industries Ltd ADR AMRN Amarin PLC ARQT Arcutis Biotherapeutics  CHRS Coherus BioSciences MYL Viatris VTRS Viatris AMAG AMAG Pharmaceuticals AUPH Aurinia Pharmaceuticals RVNC Revance The EYPT Eyepoint Pharmaceuticals ISEE IVERIC bio TXMD TherapeuticsMD AERI Aerie Pharmaceuticals . BLCO Bausch + Lomb Corp BHC Bausch Health Companies OCUL Ocular Therapeutix TAK Takeda Pharmaceutical Co Ltd ADR

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


2 years 3 months 5 days ago

0/1 (0%)

$34.88 (99.32%)



$0.78 (9.49%)


2 years 4 months 3 days ago

0/4 (0%)

$2.47 (40.09%)



$-0.22 (-2.68%)


2 years 4 months 9 days ago

4/8 (50%)

$-0.07 (-0.87%)




2 years 4 months 10 days ago

4/8 (50%)

$9.25 (194.74%)




$-2.22 (-27.01%)


2 years 4 months 10 days ago

0/2 (0%)

$3.2 (23.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ken Cacciatore?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?